Published January 18, 2022 | Version v1
Journal article Open

The Change in Vitamin D Levels during the Early Days of Intensive Care Unit ‎Admission and Factors Affecting Change

  • 1. Department of Pulmonology, Erciyes University Faculty of Medicine‎, Kayseri, Turkey.
  • 2. ‎‎Department of Internal Medicine, Division of ‎ Intensive Care‎‎, Ankara University Faculty of Medicine‎, Ankara, Turkey.‎

Description

Abstract

In the last decade, vitamin D has an increasing importance due to its demonstrated pleotropic, antimicrobial, and immunomodulatory effects, and has been a subject of interest especially in critically ill patients due to its role on immune functions. The aim of this study is to determine whether vitamin D levels change ‎during the first days of intensive care unit (ICU) admission and to study factors that may ‎affect these variations. Patients admitted to the ICU between March 2014 and December 2014 were ‎included in the study. Blood samples were obtained on the admission day, and the following ‎three days and 25-hydroxyvitamin D levels were measured by high pressure liquid ‎chromatography (HPLC) technique. Changes over time were analyzed with variance analysis ‎if they were normally distributed, otherwise by Friedman tests. ‎A total of 31 patients were enrolled. Of those, 17 (54.8%) patients were women. On ‎admission median vitamin D level for all was 8.52 (5-37) ng/mL. On the third day median ‎vitamin D level for all was 8.85 (5-35.1) ng/mL. There was no statistically significant ‎difference between vitamin D levels which were measured on the consequent 3 days ‎‎(p=0.553). There was no significant correlation between daily vitamin D levels and changes in levels of CRP, ‎procalcitonin, and albumin (p=0.061, p=0.61, p=0.179 respectively) or daily fluid balance (first day p=0.31, second day p=0.65, third day p=0.13). Our presented data revealed that repeated measurements of early vitamin D levels on consequent days did not ‎have significant differences and CRP, procalcitonin, albumin levels, and fluid balance parameters ‎do not ‎seem to affect early serum vitamin D levels in critically ill patients‎‎.

Özet

D vitamini son on yılda gösterilmiş pleotropik, antimikrobial ve immünmodülatör etkileri ‎sebebi ile giderek artan bir öneme sahip olup kritik hastalarda özellikle immün fonksiyonlar ‎üzerindeki rolü sebebi ile de ilgi konusu olmuştur. Bu çalışmanın amacı; yoğun bakım ünitesine (YBÜ) ‎kabulün ilk günlerinde D vitamini düzeylerinin değişip değişmediğini belirlemek ve bu değişiklikleri etkileyebilecek faktörleri ‎araştırmaktır. Çalışmaya Mart 2014 ile Aralık 2014 tarihleri arasında yoğun bakım ünitesine alınan hastalar dahil edildi. Hastaların yatış gününde ve takip eden üç gün içinde kan örnekleri alındı ve HPLC (yüksek basınç sıvı kromatografisi) yöntemi ile 25-hidroksivitamin D düzeyleri ‎ölçüldü. Zamana göre değişimler, dağılım normal ise varyans analizi ‎ile, dağılım normal değilse Friedman testi ile araştırıldı.‎ Toplamda 31 hasta çalışmaya dahil edilmiştir. Bu hastaların 17’si (%54.8) kadındır. ‎Hastaların yoğun bakıma alınması esnasında ortanca vitamin D düzeyi 8.52 (5-‎‎37) ng/mL idi. Üçüncü günde ise ortanca D vitamini düzeyi 8.85 (5-35.1) ng/mL olarak saptandı. Hastaların D vitamini düzeylerinde birbirini takip eden üç gün arasında anlamlı bir ‎değişiklik saptanmadı (p=0.553). D vitamininin günlük düzeyleri ile CRP, prokalsitonin ve albümin düzeylerindeki (sırası ile p=0.061, p=0.61, p=0.179) veya sıvı balansındaki (birinci gün p=0.31, ikinci gün p=0.65, üçüncü gün p=0.13) değişimler arasında anlamlı bir korelasyon ‎görülmedi. Çalışma verilerimiz yoğun bakıma yatışın ilk günlerinde tekrarlayan ölçümlerde D vitamini düzeyinin anlamlı bir değişiklik ‎göstermediğini ve kritik hastalığı olan bireylerde CRP, prokalsitonin, albümin ve sıvı balansı parametrelerinin D vitamini düzeylerini etkilemediğini göstermektedir‎‎.

Notes

Yoğun Bakıma Yatışın İlk Günlerinde D Vitamini Düzeylerindeki Değişim ve ‎Değişimi ‎Etkileyen Faktörler‎

Files

lms.2022.11.z.pdf

Files (416.6 kB)

Name Size Download all
md5:b307ef0cc7d706160fdb3df65a26cc26
416.6 kB Preview Download

Additional details

References

  • ‎1. Bikle D. Nonclassic actions of vitamin D. J Clin ‎Endocrinol Metab 2009; 94(1): 26-34. ‎‎‎
  • ‎2.‎ Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: Classic and ‎Novel Actions. Ann Nutr Metab 2018; 72(2): 87-95. ‎‎ ‎
  • ‎3.‎ Dou R, Ng K, Giovannucci EL, Manson JE, Qian ZR, ‎Ogino S. Vitamin D and colorectal cancer: molecular, ‎‎‎epidemiological and clinical evidence. Br J Nutr 2016; ‎‎115(9): 1643-60. ‎
  • ‎4.‎ Nitsa A, Toutouza M, Machairas N, Mariolis A, Philippou ‎A, Koutsilieris M. Vitamin D in Cardiovascular Disease. In ‎‎Vivo 2018; 32(5): 977-81. ‎
  • ‎5.‎ Latic N, Erben RG. Vitamin D and Cardiovascular ‎Disease, with Emphasis on Hypertension, Atherosclerosis, ‎and ‎Heart ‎Failure. Int J Mol Sci 2020; 21(18): 6483. ‎‎ ‎
  • ‎6.‎ Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 ‎Diabetes Mellitus, Insulin Resistance, and Vitamin D. Curr ‎‎Diab ‎Rep 2019; 19(10): 101. ‎
  • ‎7.‎ Rech MA, Hunsaker T, Rodriguez J. Deficiency in 25-‎hydroxyvitamin D and 30-day mortality in patients with ‎‎severe ‎sepsis and septic shock. Am J Crit Care 2014; ‎‎23(5): e72-9. ‎
  • ‎8.‎ Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. ‎Vitamin D and critical illness: what endocrinology can ‎learn ‎from ‎intensive care and vice versa. Endocr Connect ‎‎2018; 7(12): R304-R315. ‎ ‎
  • ‎9.‎ Braun A, Chang D, Mahadevappa K, Gibbons FK, Liu Y, ‎Giovannucci E, et al. Association of low serum 25-‎‎‎hydroxyvitamin D levels and mortality in the critically ill. ‎Crit Care Med 2011; 39(4): 671-7. ‎
  • ‎10.‎ Zajic P, Amrein K. Vitamin D deficiency in the ICU: a ‎systematic review. Minerva Endocrinol 2014; 39(4): 275-‎‎‎‎87. ‎
  • ‎11.‎ Lips P, Cashman KD, Lamberg-Allardt C, Bischoff-‎Ferrari HA, Obermayer-Pietsch B, Bianchi ML, et al. ‎Current ‎vitamin D status in European and Middle East ‎countries and strategies to prevent vitamin ‎D deficiency: ‎a position ‎statement of the European Calcified Tissue ‎Society. Eur J Endocrinol 2019; 180(4): P23-P54. ‎‎ ‎
  • ‎12.‎ Amrein K, Scherkl M, Hoffmann M, Neuwersch-‎Sommeregger S, Köstenberger M, Tmava Berisha A, et ‎al. ‎Vitamin D deficiency 2.0: an update on the current ‎status worldwide. Eur J Clin Nutr 2020; 74(11): 1498-‎‎513. ‎‎ ‎
  • ‎13.‎ Krishnan A, Ochola J, Mundy J, Jones M, Kruger P, ‎Duncan E, et al. Acute fluid shifts influence the ‎‎assessment ‎of serum vitamin D status in critically ill ‎patients. Crit Care 2010; 14(6): R216. ‎‎‎
  • ‎14.‎ Keyfi F, Nahid S, Mokhtariye A, Nayerabadi S, Alaei ‎A, Varasteh A-R. Evaluation of ‎‎25-OH vitamin D by high ‎‎‎performance liquid chromatography: validation and ‎comparison ‎with electrochemiluminescence. Journal of ‎‎Analytical ‎Science and Technology 2018; 9(1): 1-‎‎6.‎ ‎‎ ‎
  • ‎15.‎ Lucidarme O, Messai E, Mazzoni T, Arcade M, du ‎Cheyron D. Incidence and risk factors of vitamin D ‎deficiency ‎in ‎critically ill patients: results from a ‎prospective observational study. Intensive Care Med ‎‎2010; 36(9): 1609-11. ‎
  • ‎16.‎ Arnson Y, Gringauz I, Itzhaky D, Amital H. Vitamin D ‎deficiency is associated with poor outcomes and ‎‎increased ‎mortality in severely ill patients. QJM 2012; ‎‎105(7): 633-9. ‎
  • ‎17.‎ Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera ‎C, Luque de Castro MD, Pavón RG, Quesada Gómez JM. ‎‎‎Evaluation of vitamin D endocrine system (VDES) status ‎and response to treatment of patients in intensive care ‎‎units ‎‎(ICUs) using an on-line SPE-LC-MS/MS method. J ‎Steroid Biochem Mol Biol 2010; 121(1-2): 452-5. ‎‎ ‎
  • ‎18.‎ Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. ‎Vitamin D-binding protein influences total circulating ‎levels ‎of ‎‎1,25-dihydroxyvitamin D3 but does not directly ‎modulate the bioactive levels of the hormone in vivo. ‎‎Endocrinology ‎‎2008; 149(7): 3656-67. ‎‎‎
  • ‎19.‎ Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. ‎Free 25-hydroxyvitamin D levels are normal in subjects ‎‎with liver ‎disease and reduced total 25-hydroxyvitamin D ‎levels. J Clin Invest 1986; 78(3): 748-52. ‎‎‎
  • ‎‎20.‎ Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon ‎PM, Clinton SK, et al. The 2011 report on dietary ‎reference ‎intakes for calcium and vitamin ‎D from the ‎Institute of Medicine: what clinicians need to know. J Clin ‎Endocrinol ‎Metab 2011; 96(1): 53-8. ‎
  • ‎21.‎ Kelly DG. Guidelines and available products for ‎parenteral vitamins and trace elements. JPEN J Parenter ‎‎Enteral Nutr 2002; 26(5 Suppl): S34-6. ‎‎‎
  • ‎22.‎ Van den Berghe G, Van Roosbroeck D, Vanhove P, ‎Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in ‎‎prolonged ‎critical illness: effect of vitamin D. J Clin ‎Endocrinol Metab 2003; 88(10): 4623-32. ‎‎‎
  • ‎23.‎ Singer P, Blaser AR, Berger MM, Alhazzani W, Calder ‎PC, Casaer MP, et al. ESPEN guideline on clinical nutrition ‎‎in the intensive ‎care unit. Clin Nutr 2019; 38(1): 48-79. ‎‎ ‎
  • ‎24.‎ Autier P, Gandini S. Vitamin D supplementation and ‎total mortality: a meta-analysis of randomized controlled ‎trials. ‎‎Arch Intern Med 2007; 167(16): 1730-7. ‎‎‎